Hematology Profiles in Colorectal Cancer Patients in Bali
Article Sidebar
Main Article Content
Abstract
Colorectal cancer is a leading cause of cancer-related deaths worldwide. This study
explores blood profile and cancer staging in colorectal cancer patients in Bali. It was a
descriptive-analytical study that collected demographic and clinical data from medical
records of colorectal cancer patients at Prof. Dr. I.G.N.G. Ngoerah Hospital. The results
of the study showed the basic characteristics and hematology profiles of 100 colorectal
cancer patients. The average age of patients was 55.6 ± 11.4 years, with 54% of the total
sample being male. The average body mass index (BMI) was 21.1 ± 3.6 kg/m², with an
average height of 161.9 ± 6.1 cm and an average weight of 55.3 ± 10.0 kg. Laboratory
tests revealed an average hemoglobin (Hb) level of 11.0 ± 3.6 g/dL, red blood cell count
of 4.0 ± 0.9 million/μL, white blood cell count of 11.2 ± 7.3 thousand/μL, and platelet
count of 302.8 ± 154.8 thousand/μL. The average hematocrit (HCT) level was 33.7 ±
6.6 L/L. Liver function parameters indicated average aspartate aminotransferase
(AST/SGOT) levels of 45.6 ± 63.6 U/L and alanine aminotransferase (ALT/SGPT)
levels of 24.6 ± 29.4 U/L. Renal function was described by an average blood urea
nitrogen (BUN) level of 21.8 ± 21.0 mg/dL, urea levels of 21.9 ± 21.2 mg/dL, and
creatinine levels of 2.3 ± 11.5 mg/dL. Our study highlights the importance of
hematology profiles in colorectal cancer patients as part of cancer screening
examination. Further study with a larger number of samples and more diverse
populations is needed to analyze the relation between variables.
Downloads
Article Details
Copyright (c) 2025 Ida Kurniawati, Anak Agung Ayu Asri Prima Dewi, Fransiscus Fiano Anthony Kerans, Ni Putu Diah Witari, A A I Ayesa Febrinia Adyasputri, Made Agus Dwianthara Sueta
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Bretthauer, M. (2011). Colorectal cancer screening. Journal of Internal Medicine, 270(2), 87–98. https://doi.org/10.1111/j.1365-2796.2011.02399.x
Demb, J., Kolb, J. M., Dounel, J., Fritz, C. D. L., Advani, S. M., Cao, Y., Coppernoll-Blach, P., Dwyer, A. J., Perea, J., Heskett, K. M., Holowatyj, A. N., Lieu, C. H., Singh, S., Spaander, M. C. W., Vuik, F. E. R., & Gupta, S. (2024). Red Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer. JAMA Network Open, 7(5), e2413157. https://doi.org/10.1001/jamanetworkopen.2024.13157
Elshami, M., Ayyad, M., Alser, M., Al-Slaibi, I., Ahmed Naji, S., Mohamad, B. M., Sudki Isleem, W., Shurrab, A., Yaghi, B., Qabaja, Y. A., Hmdan, F. K., Fuad Dwikat, M., Raed Sweity, R., Jneed, R. T., Assaf, K. A., Albandak, M. E., Madhat Hmaid, M., Awwad, I. I., Khalil Alhabil, B., … Bottcher, B. (2022). Awareness of colorectal cancer signs and symptoms: a national cross-sectional study from Palestine. BMC Public Health, 22(1), 866. https://doi.org/10.1186/s12889-022-13285-8
Esteva, M., Leiva, A., Ramos, M., Pita-Fernández, S., González-Luján, L., Casamitjana, M., Sánchez, M. A., Pértega-Díaz, S., Ruiz, A., Gonzalez-Santamaría, P., Martín-Rabadán, M., Costa-Alcaraz, A. M., Espí, A., Macià, F., Segura, J. M., Lafita, S., Arnal-Monreal, F., Amengual, I., Boscá-Watts, M. M., … Magallón, R. (2013). Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer. BMC Cancer, 13(1), 87. https://doi.org/10.1186/1471-2407-13-87
Galon, J., Mlecnik, B., Marliot, F., Ou, F.-S., Bifulco, C. B., Lugli, A., Zlobec, I., Rau, T. T., Hartmann, A., Masucci, G. V, Zavadova, E., Ohashi, P., Roehrl, M. H. A., Kawakami, Y., Torigoe, T., Ascierto, P. A., Marincola, F., Sargent, D. J., Fox, B. A., & Pages, F. (2016). Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients. Journal of Clinical Oncology, 34(15_suppl), 3500–3500. https://doi.org/10.1200/JCO.2016.34.15_suppl.3500
Graham, J. S., & Cassidy, J. (2012). Adjuvant therapy in colon cancer. Expert Review of Anticancer Therapy, 12(1), 99–109. https://doi.org/10.1586/era.11.189
Maida, M., Macaluso, F. S., Ianiro, G., Mangiola, F., Sinagra, E., Hold, G., Maida, C., Cammarota, G., Gasbarrini, A., & Scarpulla, G. (2017). Screening of colorectal cancer: present and future. Expert Review of Anticancer Therapy, 17(12), 1131–1146. https://doi.org/10.1080/14737140.2017.1392243
Majano, S. B., Lyratzopoulos, G., Rachet, B., de Wit, N. J., & Renzi, C. (2022). Do presenting symptoms, use of pre-diagnostic endoscopy and risk of emergency cancer diagnosis vary by comorbidity burden and type in patients with colorectal cancer? British Journal of Cancer, 126(4), 652–663. https://doi.org/10.1038/s41416-021-01603-7
Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., & Rodriguez Yoldi, M. (2017). Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. International Journal of Molecular Sciences, 18(1), 197. https://doi.org/10.3390/ijms18010197
Novotny, S. A., Rodrigo Amador, V. A., Seguí Orejuela, J., López-Pineda, A., Quesada, J. A., Pereira-Expósito, A., Carratalá-Munuera, C., Hernandis Villalba, J., & Gil-Guillén, V. F. (2024). Prognostic Study of Colorectal Cancer: Differences between Screen-Detected and Symptom-Diagnosed Patients. Cancers, 16(19), 3363. https://doi.org/10.3390/cancers16193363
Rex, D. K., Schoenfeld, P. S., Cohen, J., Pike, I. M., Adler, D. G., Fennerty, B. M., Lieb, J. G., Park, W. G., Rizk, M. K., Sawhney, M. S., Shaheen, N. J., Wani, S., & Weinberg, D. S. (2015). Quality Indicators for Colonoscopy. American Journal of Gastroenterology, 110(1), 72–90. https://doi.org/10.1038/ajg.2014.385
Saraste, D., Martling, A., Nilsson, P., Blom, J., Törnberg, S., & Janson, M. (2017). Screening vs. non-screening detected colorectal cancer: Differences in pre-therapeutic work up and treatment. Journal of Medical Screening, 24(2), 69–74. https://doi.org/10.1177/0969141316656216
Saratzis, A., Winter-Beatty, J., El-Sayed, C., Pande, R., & Harmston, C. (2015). Colorectal cancer screening characteristics of patients presenting with symptoms of colorectal cancer and effect on clinical outcomes. The Annals of The Royal College of Surgeons of England, 97(5), 369–374. https://doi.org/10.1308/003588415X14181254789565
Sarwono, J. (2013). Strategi Melakukan Riset, Kuantitatif, Kualitatif, Gabung. Penerbit Andi.
Schoen, R. E., Razzak, A., Yu, K. J., Berndt, S. I., Firl, K., Riley, T. L., & Pinsky, P. F. (2015). Incidence and Mortality of Colorectal Cancer in Individuals With a Family History of Colorectal Cancer. Gastroenterology, 149(6), 1438-1445.e1. https://doi.org/10.1053/j.gastro.2015.07.055
Schult, A. L., Botteri, E., Hoff, G., Randel, K. R., Dalén, E., Eskeland, S. L., Holme, Ø., & de Lange, T. (2021). Detection of cancers and advanced adenomas in asymptomatic participants in colorectal cancer screening: a cross-sectional study. BMJ Open, 11(7), e048183. https://doi.org/10.1136/bmjopen-2020-048183
Shkurti, J., van den Berg, K., van Erning, F. N., Lahaye, M. J., Beets-Tan, R. G. H., & Nederend, J. (2023). Diagnostic accuracy of CT for local staging of colon cancer: A nationwide study in the Netherlands. European Journal of Cancer, 193, 113314. https://doi.org/10.1016/j.ejca.2023.113314
Siegel, R. L., Torre, L. A., Soerjomataram, I., Hayes, R. B., Bray, F., Weber, T. K., & Jemal, A. (2019). Global patterns and trends in colorectal cancer incidence in young adults. Gut, 68(12), 2179–2185. https://doi.org/10.1136/gutjnl-2019-319511
Srivastava, S., Verma, M., & Henson, D. E. (2001). Biomarkers for early detection of colon cancer. Clinical Cancer Research, 7(5):1118-.
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Von Karsa, L., Patnick, J., Segnan, N., Atkin, W., Halloran, S., Lansdorp-Vogelaar, I., Malila, N., Minozzi, S., Moss, S., Quirke, P., Steele, R. J., Vieth, M., Aabakken, L., Altenhofen, L., Ancelle-Park, R., Antoljak, N., Anttila, A., Armaroli, P., Arrossi, S., … Valori, R. (2012). European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication. Endoscopy, 45(01), 51–59. https://doi.org/10.1055/s-0032-1325997
